High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research funding scenario, and various technological advancements are key factors contributing to high CAGR of Tumor Ablation during forecast period.
Market Size – USD 973.4 Million in 2018, Market Growth - CAGR of 11.2%, Market Trends – Product launches and research for advanced tumor ablation
According to the current analysis of Reports and Data, the global Tumor Ablation market was valued at USD 973.4 million in 2018 and is expected to reach USD 2.30 billion by year 2026, at a CAGR of 11.2 %. The study covers Tumor Ablation therapy uses some form of energy like radiofrequency, heat, electricity or cold to destroy and remove a tumor. Tumor ablation has primarily been used for the treatment of esophageal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia.
Ablation is preferred over other methods of treatment such as conventional surgery due to multiple advantages like no skin incision minimal risk to patient, little to no pain inflicted and a short duration of hospital stay. The increasing economic impact of cancer which shows increased prevalence of cancer among the population which increases the demand for the cancer treatment. In the year 2016 US the annual cost for cancer was USD 80.2 billion of which 38% cost was estimated due to inpatient hospital stays which can be reduced to quite good extent as the tumor ablation demands short duration of hospital stay.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2029
The report provides a complete analysis of the global Tumor Ablation market with important details about the key market players from insightful primary and secondary research data. The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.
The key companies profiled in the market are:
Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc.
Further key findings from the report suggest
- Tumor Ablation market is growing at a CAGR of 12% in Asia Pacific followed by North America and Europe, with 0% and 10.9% CAGR, respectively. High cancer prevalence across the globe is the major factor driving the market during the forecast period across all regions.
- The Radiofrequency Ablation segment dominates the market with a 25% market share. It is also estimated to grow at a CAGR of 10.3% as it is more preferably used for localized tumor ablation surgery especially for malignant liver cancer as it do not require longer period of hospital stay for the pre surgery observations
- The microwave ablation segment is forecasted to be the fastest growing market segment, estimated to hold a 12.1% CAGR. Microwave ablation expects less risk and shorter duration of the hospital stay. Microwave ablation can perform for the treatment of multiple tumors simultaneously
- Based on end use, the liver cancer segment dominates the market holding a 23.0% market share and is estimated to grow at a 12.1% CAGR. For the year 2018 American Cancer Society forecasted the liver cancer cases in the US might be approximately 42,220 and is expected to keep on increasing. It is the only cancer in the US which is continuously increasing
- Asia Pacific is expected to account for the 26.6% of the global Tumor Ablation market. Developing nations such China, and India are likely to witness high growth due to uncontrolled population growth, more aged population, adherence to unhealthy habits and diet and infinite pollution growth
- Slow rate of commercialization, high costs involved in research and development, reluctance toward the adoption of new treatment practices and government regulations that require long certification and approval cycles are likely to hamper growth of the market
- One of the major manufacturer of medical device Boston Scientific acquired BTG PLC in November of the year 2018 which will expand Boston Scientific’s product line as well as it will improve the geographical reach of the company which will boost the company’s total sales along with the US regional sales. Boston Scientific also will be increasing cancer indication regarding the product of BTG, TheraSphere radiotherapy product and ICEfx cryoablation technology.
Browse Complete Report “Tumor Ablation Market” @ https://www.reportsanddata.com/report-detail/tumor-ablation-market
For the purpose of this report, Reports and Data has segmented the Tumor Ablation market on the basis of treatment, technology, application, and region:
Treatment Type Outlook (Revenue, USD Million; 2016-2026)
- Surgical Ablation
- Laparoscopic Ablation
- Percutaneous Ablation
Technology Type Outlook (Revenue, USD Million; 2016-2026)
- Radiofrequency Ablation
- Cryoablation
- Microwave Ablation
- Irreversible Electroporation
- Other Ablation Technologies
Application Type Outlook (Revenue, USD Million; 2016-2026)
- Liver Cancer
- Lung Cancer
- Breast cancer
- Prostate Cancer
- Other Cancer
The report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region. The Tumor Ablation market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
In-depth regional analysis covers:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- Rest of MEA
The report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts. The report further provides insights into the opportunities and threats that the industry may witness in the upcoming years, throughout the forecast period. The report also provides an insight into the growth in revenue along with CAGR throughout the forecast period. It also provides insights into lucrative opportunities to enable the businesses to capitalize on the emerging trends of the market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2029
Highlights of the TOC:
- Report Overview
1.1 Research Scope
1.2 Key Tumor Ablation market segments
1.3 Major players
1.4 Market analysis by product
1.5 Market analysis by application
1.6 Report timeline
- Global Growth Trends
2.1 Global Tumor Ablation market size
2.2 Latest Tumor Ablation market trends
2.3 Key growth trends
- Competitive Landscape
3.1 Global Tumor Ablation market key players
3.2 Global Tumor Ablation size by manufacturers
3.3 Products of major players
3.4 Entry barriers in the Tumor Ablation market
3.5 Mergers, acquisitions, joint ventures, and strategic alliances
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Thank you for reading our report. For additional information on customization of the report, connect with us and we will make sure you get a report tailored to meet your needs.
Tumor Ablation Market, Tumor Ablation Market size, Tumor Ablation Market share, Tumor Ablation Market trends, Tumor Ablation Market forecast, Tumor Ablation Market analysis, Tumor Ablation Market scope, Tumor Ablation Market manufacturer, Tumor Ablation Market vendors, Tumor Ablation Market players, Tumor Ablation Market top player, Tumor Ablation Market key player, Tumor Ablation Market prominent player, Tumor Ablation Market major manufacturers, Tumor Ablation Market report .
Market Size – USD 3,004.6 Million in 2018, Market Growth - CAGR of 18.2%, Market Trends – Product launches and research for advanced teleradiology practices According to the current analysis of Reports and Data, the global Teleradiology market was valued at USD 3,004.6 million in 2018 and is expected to reach USD 11,423.4 million by the year 2026, at a CAGR of 18.2%.
Teleradiology is the process of transference of radiological patient images from one place to another for either official diagnosis or consultation with other radiologists and physicians.
Digital image processing methods and sundry wireless technology can provide immense benefits to this market globally.The growing number of imaging tests, rising R activities related to eHealth, and increasing implementation of picture archiving and communication systems are some of the factors estimated to stimulate the growth of the market.
Given the saturated nature of the outsourced, preliminary teleradiology market and the need for large teleradiology companies to grow, the companies’ focus has recently expanded to the acquisition of existing hospital radiology contracts.
Virtual Radiologic (vRad), a major national teleradiology firm, recently announced that it would cut the pay of its contracted radiologists.
It is used by urgent care clinics, hospitals, and mobile imaging companiesThe growing number of imaging tests, rising R activities related to eHealth, and increasing implementation of picture archiving and communication systems are some of the factors boosting the growth of the marketSiemens Healthineers, in collaboration with GE Healthcare, launched a Go platform cardiac CT scanner in March 2019, boosting demand from Hospitals and ClinicsGrowing target population base coupled with the increasing prevalence of chronic diseases, such as cancer, cardiac diseases, bone impairments, and liver diseases, are the major factors contributing to the North American region’s largest revenue share of nearly 40% of the marketDiagnostic centers are expected to high CAGR during the forecast periodX-rays are the leading technique sub- segment of the global teleradiology market with a large market share of 41.1%, as it is having wide applications in various healthcare domains, such as orthopedics, cardiovascular diagnostics, chest imaging, cancer screening, and dental imagingContinuous advancements in medical diagnostic technologies are expected to provide lucrative opportunities for the growth of the teleradiology players during the forecast periodThe key companies profiled in the market are: Siemens AG, Teleradiology Solutions (TRS), Global Diagnostics Limited., Mednax, Inc., Onrad, Inc., Telediagnostics Services Pvt.
The Global Bovine Blood Plasma Derivatives Market research report published by Reports and Data offers a comprehensive evaluation of the Bovine Blood Plasma Derivatives market on the global scale and sheds light on the growth opportunities, prospects, and enables the readers to formulate strategic plans.
The report offers an in-depth analysis of the value chain, upstream and downstream factors, sales network and distribution channels, growth trends, driving and restraining factors, developments, production and consumption pattern, end-users, and regional segmentation.
The report also offers relevant and useful information to help the new entrants and established companies strengthen their market position.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3508The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data.
It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans.
The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.Key Manufacturers in the Global Bovine Blood Plasma Derivatives Market:LAMPIRE Biological Laboratories, Inc., Sigma-Aldrich Co. (Merck KGaA), Rocky Mountain Biologicals Inc., Proliant Inc., Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3508The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions.
It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region.
High demand for metabolomics from various research institutes and pharmaceutical & biotechnology companies is a key factor driving market revenue growthThe global metabolomics market size is expected to reach USD 5.10 Billion in 2028 and register a CAGR of 13.2% over the forecast period, according to the latest report by Reports and Data.
In addition, in developed countries, presence of state-of-the-art healthcare infrastructure for precise diagnosis and treatment of various disorders is expected to drive market growth during the forecast period.Demand for metabolomics is increasing because of its ability to work as a drug discovering tool.
Metabolomics is utilized for discovering different types of drugs as it can improve testing and discovery of novel drugs.However, lack of awareness about metabolomics in underdeveloped countries, complexity of data generated during research activities, lack of advanced healthcare facilities in emerging countries, and high cost of novel tools and equipment can hamper market growth over the forecast period.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4641Some Key Highlights From the Report:By application, biomarker discovery segment accounted for the largest revenue share in 2020.
Rising awareness among people, presence of a well-developed healthcare infrastructure for supporting R activities, and technological advancements are anticipated to propel growth of this region.
Apart from that, increasing geriatric population and rising number of research & development activities in the field of metabolomics would also drive revenue growth of the market in this region.Regional Outlook:North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions.
As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.Get a Discount @ https://www.reportsanddata.com/discount-enquiry-form/4641Competitive Outlook:The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry.
Rising number of cancer cases, growing incidence of infectious diseases, strong government funding for medical science and the increasing application of patient-specific treatments are key factors contributing to high CAGR of Molecular Diagnostics during the forecast period.Market Size – USD 7.28 Billion in 2018, Market Growth - CAGR of 8.2%, Market Trends – impressive growth in colorectal cancer molecular diagnostics marketThe report on the global Molecular Diagnostics Market published by Reports and Data provides an in-depth assessment of the Molecular Diagnostics market including recent technological and product advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, and other key features.
The report comprises 100+ pages and covers comprehensive assessment of market size, market share, revenue contribution, revenue share, growth rate, industrial chain analysis, regional analysis, and top companies.
It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.Get a sample of the report @ https://reportsanddata.com/sample-enquiry-form/945The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations.
The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.Key players in the market include Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., CepheidFor a better understanding of the global Molecular Diagnostics market dynamics, a regional analysis of the market across key geographical areas is offered in the report.
The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market.
The ‘Carotenoids Market Report: COVID-19 Impact Analysis Forecast to 2027’ published by Reports and Data gives a holistic overview of the Carotenoids market.
The report segments the market to help readers get a more in-depth understanding of the different aspects of the market.The report also examines the financial standing of leading companies in detail, which consists of market position, gross profit, overall revenue, sales volume, manufacturing, growth rate, and other vital facts & figures.
The study also highlights production capacity, consumer base, value, volume, product offerings, upstream suppliers, downstream buyers, market concentration rate, and leading regions to give an exhaustive evaluation of the global landscape.The research study consists of the latest updates about the COVID-19 impact on the Carotenoids sector.
The outbreak has virtually influenced the entire global economic landscape.
The report evaluates the current situation of the business and studies the possible aftereffects of the outbreak on the overall industry.Get a Sample Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1269Leading Carotenoids manufacturers/companies in the market:BASF, Allied Biotech, AquaCarotene, Algatechnologies, Kemin Industries, Cyanotech Corp., Brenntag, Divis Laboratories, Naturex SA, DSM Nutritional Products, D.D.
It discusses the growth prospects of different market segments by examining the current market setting, historical performance, demand and supply ratio, production, consumption, sales, and revenue of leading companies in the market.
Pharmacovigilance Market This is the most efficiently and meticulously put together report which will help the user to better understand the opportunities and threats that are doled by the industry and its players.
In this report, several aspects of the market research and analysis for the Chemical and Materials industry have been underlined.
The report serves the analysis of the global market share, segmentation, revenue growth estimation, and geographic regions of the market.Pharmacovigilance Market will reach an estimated valuation of USD 11.54 billion by 2027 while registering this growth at a rate of 13.1% for the forecast period of 2020 to 2027.The study proves to be unique due to the inclusion of the impact of the coronavirus on the market.
All industries have been severely affected by the virus and this report assesses the market, keeping in mind the possible aftereffects of the pandemic.To get your copy of the Pharmacovigilance market report @ https://www.reportsanddata.com/sample-enquiry-form/2253The influential and dominant players of the Pharmacovigilance global market are:- Accenture, Clinquest Group B.V., Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc.
Capgemini, ITClinical, IMD global, Foresight Group International AG, TAKE Solutions Ltd., PAREXEL International Corporation, BioClinica, Wipro Ltd., and United BioSource Corporation., among others.The study encompasses leading regions of the Pharmacovigilance industry.
These regions are:North AmericaS.CanadaEuropeGermanyK.FranceItalySpainRussiaAsia PacificChinaIndiaJapanAustraliaSouth KoreaNew ZealandRest of APACLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East and AfricaA.E.Saudi ArabiaSouth AfricaRest of MEA Avail Discount on the Pharmacovigilance Market Report @ https://www.reportsanddata.com/discount-enquiry-form/2253 Global Pharmacovigilance Market Scope and Market SizeThe study is segmented and sub-segmented into types, applications, regions, products, players, and growth that was observed.
